NASDAQ: IRD
Opus Genetics Inc Stock Ownership - Who owns Opus Genetics?

Insider buying vs selling

Have Opus Genetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nirav S. JhaveriChief Financial Officer2025-02-138,207$1.15
$9.44kSell
Ashwath JayagopalChief Scientific Dev. Ofc.2025-02-135,193$1.15
$5.97kSell
Bernhard HoffmannSVP of Corp. Dev.2025-02-046,751$1.14
$7.70kSell
Rabourn Amy ZarembaSVP of Finance2025-02-048,190$1.14
$9.34kSell
George MagrathChief Executive Officer2024-12-26100,000$0.98
$97.60kBuy
Benjamin R. YerxaPresident2024-11-2110,000$0.98
$9.83kBuy
George MagrathChief Executive Officer2024-11-189,706$1.02
$9.94kBuy
George MagrathChief Executive Officer2024-11-1590,294$1.01
$91.20kBuy
George MagrathChief Executive Officer2024-11-0137,050$1.18
$43.72kSell

1 of 1

IRD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRD insiders and whales buy or sell their stock.

IRD Shareholders

What type of owners hold Opus Genetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sungkee Chung274.55%163,800,000$163.80MInsider
Sung Sook Park117.66%70,200,000$70.20MInsider
Frank Ferraro43.58%26,000,000$26.00MInsider
Inok Ahn23.47%14,000,000$14.00MInsider
Chang Ho Ahn19.29%11,510,000$11.51MInsider
Foundation Fighting Blindness Retinal Degeneration Fund15.91%9,492,171$9.49MInsider
Rexgene Biotech Co Ltd9.23%5,505,956$5.51MInsider
Perceptive Advisors LLC7.25%4,325,000$4.33MInstitution
Nantahala Capital Management LLC5.29%3,157,895$3.16MInstitution
Young Soon Park4.54%2,706,500$2.71MInsider

1 of 3

IRD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRD4.48%95.52%Net Buying
OTLK3.41%96.59%Net BuyingNet Buying
SER0.84%99.16%Net BuyingNet Buying
INMB25.54%31.87%Net Buying
PDSB18.00%25.86%Net Buying

Opus Genetics Stock Ownership FAQ

Who owns Opus Genetics?

Opus Genetics (NASDAQ: IRD) is owned by 24.41% institutional shareholders, 520.19% Opus Genetics insiders, and 0.00% retail investors. Sungkee Chung is the largest individual Opus Genetics shareholder, owning 163.80M shares representing 274.55% of the company. Sungkee Chung's Opus Genetics shares are currently valued at $163.80M.

If you're new to stock investing, here's how to buy Opus Genetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.